Gayn Erickson - Aehr Test CEO and President and Director
| AEHR Stock | USD 11.89 0.16 1.36% |
CEO
Mr. Gayn Erickson is a President, Chief Executive Officer, Director of the Company, since January 2012. Prior to joining the Company, Mr. Erickson served as corporate officer, Senior Vice President and General Manager of Verigy Ltd.s memory test business from February 2006 until October 2011. Prior to that, he was Vice President of Marketing and Sales for Agilent Technologies Semiconductor Memory Test products. He has over 28 years of executive and general management, operations, marketing, sales and RD program management experience, dating back to the late 1980s when he began his career in semiconductor test with HewlettPackard Automated Test Group since 2012.
| Age | 60 |
| Tenure | 12 years |
| Address | 400 Kato Terrace, Fremont, CA, United States, 94539 |
| Phone | 510 623 9400 |
| Web | https://www.aehr.com |
Gayn Erickson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Gayn Erickson against Aehr Test stock is an integral part of due diligence when investing in Aehr Test. Gayn Erickson insider activity provides valuable insight into whether Aehr Test is net buyers or sellers over its current business cycle. Note, Aehr Test insiders must abide by specific rules, including filing SEC forms every time they buy or sell Aehr Test'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Gayn Erickson over three months ago Disposition of 3570 shares by Gayn Erickson of Aehr Test at 16.43 subject to Rule 16b-3 | ||
Gayn Erickson over three months ago Disposition of 1154 shares by Gayn Erickson of Aehr Test at 16.43 subject to Rule 16b-3 | ||
Gayn Erickson over six months ago Disposition of 3463 shares by Gayn Erickson of Aehr Test at 11.55 subject to Rule 16b-3 | ||
Gayn Erickson over six months ago Disposition of 1119 shares by Gayn Erickson of Aehr Test at 11.55 subject to Rule 16b-3 |
Aehr Test Management Efficiency
The company has return on total asset (ROA) of 0.0305 % which means that it generated a profit of $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2876 %, meaning that it created $0.2876 on every $100 dollars invested by stockholders. Aehr Test's management efficiency ratios could be used to measure how well Aehr Test manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/30/2024, Return On Tangible Assets is likely to grow to 0.27. Also, Return On Capital Employed is likely to grow to 0.09. At this time, Aehr Test's Fixed Asset Turnover is relatively stable compared to the past year. As of 11/30/2024, Return On Assets is likely to grow to 0.27, while Other Current Assets are likely to drop slightly above 899.3 K.Similar Executives
| Found 8 records | CEO Age | ||
| Luis Muller | Cohu Inc | 54 | |
| Mark Jagiela | Teradyne | 63 | |
| Richard Wallace | KLA Tencor | 64 | |
| Fusen Chen | Kulicke and Soffa | 65 | |
| Mary Puma | Axcelis Technologies | 66 | |
| Richard Grant | inTest | 54 | |
| James Scholhamer | Ultra Clean Holdings | 58 | |
| Gary Dickerson | Applied Materials | 67 | |
Management Performance
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0305 |
Aehr Test Systems Leadership Team
Elected by the shareholders, the Aehr Test's board of directors comprises two types of representatives: Aehr Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aehr. The board's role is to monitor Aehr Test's management team and ensure that shareholders' interests are well served. Aehr Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aehr Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rhea Posedel, Founder and Chairman | ||
| Adil Engineer, Chief Officer | ||
| Kenneth Spink, Interim CFO | ||
| Alberto Salamone, ppbi EVP | ||
| David Hendrickson, VP of Engineering | ||
| Donald II, VP Engineering | ||
| Gayn Erickson, CEO and President and Director | ||
| Avijit RayChaudhuri, Executive RD | ||
| Chris Siu, Executive CFO | ||
| Vernon Rogers, Executive Vice President of Sales and Marketing |
Aehr Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aehr Test a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0305 | ||||
| Profit Margin | 0.50 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 316.44 M | ||||
| Shares Outstanding | 29.63 M | ||||
| Shares Owned By Insiders | 5.88 % | ||||
| Shares Owned By Institutions | 77.30 % | ||||
| Number Of Shares Shorted | 6.52 M | ||||
| Price To Earning | 70.48 X |
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Aehr Stock
Moving against Aehr Stock
| 0.49 | CAN | Canaan Inc Buyout Trend | PairCorr |
| 0.35 | RMBS | Rambus Inc | PairCorr |
| 0.31 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aehr Stock Analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.